TLR4, a modulator of innate immunity, contributes to obesity-related OA pathogenesis via mediating metabolic inflammation and cartilage catabolism in OA joints [30]. The gene discussed is TLR4; the disease is obesity due to melanocortin 4 receptor deficiency.